Overview

This initiative is targeted to addressing the professional practice of pharmacists in hospitals, health systems, ambulatory care clinics, and other settings. Attendees of this activity will gain insight into the latest clinical and scientific advances in the treatment and management of patients with chronic lymphocytic leukemia (CLL) using BTK inhibitors (BTKis), including the latest approvals, the most current safety and efficacy data, and expert insights into addressing challenges of CLL treatment using BTKis. Using a case-based approach, discussion on anticipating and managing adverse events, therapy selection, and improving adherence will be incorporated into this cutting-edge activity.

View All Speakers

Speakers

Rebecca Nelson, PharmD, BCOP


Clinical Pharmacy Coordinator, Malignant Hematology Moffitt Cancer Center Tampa, Florida
View Full Bio

Emily Dotson, PharmD, BCOP


Clinical Pharmacist Specialist–Hematology Lead The James Cancer Hospital Columbus, Ohio
View Full Bio

Kathy Edwards, PharmD, BCPS, BCOP


Affiliate Associate Professor, College of Pharmacy Medical University of South Carolina
View Full Bio

Jeanie Patrick, PharmD, BCOP


Clinical Oncology Pharmacist Baptist Health Lexington Lexington, Kentucky
View Full Bio

Accreditation

In support of improving patient care, Creative Educational Concepts is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Pharmacy (ACPE)

This application-based activity is approved for 1.0 contact hours (.10 CEUs) of continuing pharmacy education credit (JA0007101-0000-20-001-L01-P).

Upon completion of a CE request form, pharmacy credit will be reported directly to the National Association of Boards of Pharmacy® (NABP®) CPE Monitor electronic CE tracking system.